Treponema pallidum Macrolide Resistance and Molecular Epidemiology in Southern Africa, 2008 to 2018.

Venter, Johanna M E; Müller, Etienne E; Mahlangu, Mahlape P; Kularatne, Ranmini S

Venter, Johanna M E; Müller, Etienne E; Mahlangu, Mahlape P; Kularatne, Ranmini S.

Afiliación

Venter JME; Centre for HIV and Sexually Transmitted Infections, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa.
Müller EE; Centre for HIV and Sexually Transmitted Infections, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa.
Mahlangu MP; Centre for HIV and Sexually Transmitted Infections, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa.
Kularatne RS; Centre for HIV and Sexually Transmitted Infections, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa.

J Clin Microbiol ; 59(10): e0238520, 2021 09 20.

Article en En | MEDLINE | ID: mdl-34346717

Asunto(s)

Antibacterianos; Treponema pallidum; Antibacterianos/farmacología; Antibacterianos/uso terapéutico; Farmacorresistencia Bacteriana; Humanos; Macrólidos/farmacología; Epidemiología Molecular; Treponema pallidum/genética

Palabras clave

Treponema pallidum; epidemiology; macrolide resistance; southern Africa

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Treponema pallidum / Antibacterianos Tipo de estudio: Guideline / Risk_factors_studies / Screening_studies Límite: Humans Idioma: En Revista: J Clin Microbiol Año: 2021 Tipo del documento: Article País de afiliación: Sudáfrica

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google